X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2173) 2173
Publication (249) 249
Book / eBook (68) 68
Book Chapter (25) 25
Book Review (15) 15
Conference Proceeding (6) 6
Dissertation (5) 5
Reference (4) 4
Magazine Article (1) 1
Newspaper Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1395) 1395
female (1043) 1043
index medicus (968) 968
oncology (918) 918
male (822) 822
adult (603) 603
chemotherapy (535) 535
adolescent (451) 451
child (444) 444
intergroup (427) 427
middle aged (388) 388
psychology, social (382) 382
antineoplastic combined chemotherapy protocols - therapeutic use (364) 364
cancer (363) 363
intergroup relations (348) 348
intergroup rhabdomyosarcoma (333) 333
treatment outcome (321) 321
child, preschool (310) 310
aged (309) 309
prejudice (293) 293
prognosis (275) 275
children (274) 274
intergroup trial (258) 258
combined modality therapy (256) 256
young adult (243) 243
research (242) 242
rhabdomyosarcoma (241) 241
radiotherapy (240) 240
disease-free survival (238) 238
pediatrics (238) 238
analysis (227) 227
surgery (222) 222
neoplasm staging (221) 221
infant (211) 211
social psychology (208) 208
attitudes (200) 200
hematology (200) 200
retrospective studies (199) 199
survival (185) 185
care and treatment (179) 179
survival analysis (176) 176
survival rate (170) 170
therapy (169) 169
cisplatin (166) 166
tumors (163) 163
behavior (150) 150
psychology (145) 145
follow-up studies (143) 143
hematology, oncology and palliative medicine (143) 143
prognostic-factors (143) 143
ovarian neoplasms - drug therapy (136) 136
social identity (136) 136
bias (131) 131
sarcoma (131) 131
randomized-trial (130) 130
ovarian cancer (129) 129
group dynamics (126) 126
studies (126) 126
radiation-therapy (124) 124
management (123) 123
antineoplastic combined chemotherapy protocols - administration & dosage (121) 121
antineoplastic combined chemotherapy protocols - adverse effects (121) 121
stereotypes (120) 120
intergroup contact (118) 118
trial (118) 118
aged, 80 and over (117) 117
paclitaxel (117) 117
carboplatin (116) 116
article (112) 112
discrimination (112) 112
social identification (112) 112
cyclophosphamide (110) 110
interpersonal relations (108) 108
social perception (107) 107
carcinoma (106) 106
psychological aspects (106) 106
social aspects (106) 106
risk factors (103) 103
antineoplastic agents - therapeutic use (101) 101
phase-iii trial (101) 101
race (99) 99
rhabdomyosarcoma - therapy (99) 99
childhood (98) 98
medicine & public health (97) 97
chemotherapy, adjuvant (95) 95
cisplatin - administration & dosage (95) 95
health aspects (94) 94
rhabdomyosarcoma - pathology (94) 94
soft-tissue sarcoma (92) 92
identity (90) 90
experience (88) 88
obstetrics & gynecology (86) 86
clinical trials as topic (85) 85
radiology, nuclear medicine & medical imaging (85) 85
self (84) 84
1st-line treatment (83) 83
motivation (82) 82
ovarian neoplasms - pathology (82) 82
time factors (81) 81
adjuvant chemotherapy (80) 80
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (49) 49
UofT at Mississauga - Stacks (18) 18
UTL at Downsview - May be requested (13) 13
OISE - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
UofT at Scarborough - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Indust. Rel's & Hum. Resources (Newman) - Library use only (3) 3
Gerstein Science - Stacks (2) 2
New College (Ivey) - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (1) 1
Law (Bora Laskin) - Closed Orders (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Curriculum Resources (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2249) 2249
German (10) 10
French (9) 9
Spanish (7) 7
Japanese (4) 4
Arabic (2) 2
Hebrew (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2484 - 2496
The addition of bevacizumab to chemotherapy (15 mg/kg for six cycles) followed by extended therapy with bevacizumab every 3 weeks for a total of 15 months of... 
CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | GYNECOLOGIC-ONCOLOGY-GROUP | SOLID TUMORS | ANGIOGENESIS | CYCLOPHOSPHAMIDE | EXPRESSION | INTRAPERITONEAL CISPLATIN | III TRIAL | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Combined Modality Therapy | Ovarian Neoplasms - mortality | Neoplasms, Glandular and Epithelial - surgery | Bevacizumab | Disease-Free Survival | Neoplasms, Glandular and Epithelial - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Carcinoma, Ovarian Epithelial | Quality of Life | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Risk groups | Body weight | Clinical trials | Survival | Angiogenesis | Chemotherapy | Womens health | Paclitaxel | Carboplatin | Vascular endothelial growth factor | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1295 - 1305
Journal Article
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 78 - 89
Summary Background Angiogenesis is a target in the treatment of ovarian cancer. Nintedanib, an oral triple angiokinase inhibitor of VEGF receptor,... 
Hematology, Oncology and Palliative Medicine | BIBF 1120 | DES CANCERS | INTERGROUP TRIAL | LABEL DOSE-ESCALATION | CISPLATIN | ONCOLOGY | BEVACIZUMAB | TRIPLE ANGIOKINASE INHIBITOR | CARBOPLATIN PLUS PACLITAXEL | III TRIAL | MAINTENANCE THERAPY | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Diarrhea - chemically induced | Cytoreduction Surgical Procedures | Indoles - administration & dosage | Young Adult | Peritoneal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Double-Blind Method | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Anemia - chemically induced | Carboplatin - administration & dosage | Fallopian Tube Neoplasms - pathology | Thrombocytopenia - chemically induced | Disease Progression | Disease-Free Survival | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fallopian Tube Neoplasms - surgery | Intention to Treat Analysis | Aged | Neoplasm Staging | Ovarian Neoplasms - surgery | Clinical trials | Chemotherapy | Hospitals | Growth factors | Cancer | Ovarian cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Journal Article